Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly Human Leukocyte Antigen-Sensitized Patients Awaiting Kidney Transplantation
Authors:
- Shehzad RehmanSRShehzad Rehman
- Herwig-Ulf Meier-KriescheHMHerwig-Ulf Meier-Kriesche
- Juan ScornikJSJuan Scornik
- 27 October 2010
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 90 (8) , 932-3
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney TransplantationTransplantation, 2010
- Is Rituximab Safe to Use in Kidney Transplant Patients?American Journal of Transplantation, 2009